Flatlander

JdeFLI can accept my loss and move on but I think that the stock exchange owes investors more of an investigation, If BCART was just mismanaged into essentially the equivalent of Bancrupcy, then...

With todays announcement of the recapitalization, It is apparent that FSMA will take no action. If they intended to perform a legitimate oversight investigation there would have been some sort of te...

Well given the slow down in the chatter, Im guessing little is being done. I dont have much faith in FSMA following through in investigating even though the requests were pretty manageable....

I suspect the GHDX or EXAS deal for the oncotype Dx breast cancer test is the one where BCART delayed notice to shareholders. At the time I debated selling out, but decided to give BCART an additiona...

Im confused by much of what I read on this board. Euro Trader, what is the basis for this statement.Verelst will undoubtedly face a prison sentence, given the incriminating objections ...

You can say what you want about shareholders being naive about BCARTs and its precarious financing, however, their is considerable evidence that shareholders were also misled. Verrelst told us succes...

I decided not to join since they were not proposing the litigation and discovery I feel is necessary, I have requested that FSMA look into items I outlined, However I doubt much action will be taken...

And so it Begins. The secured creditors are moving to sever the existing shareholders from their shares. It is appropriate that this occur on Halloween, since the management of BCART has been a sp...

Anyone have an Idea of how Item #7 could be approved during the Oct 27, 2022 meeting when items 2-6 could not voted on due to a lack of a quorum? Item 7 authorized allowing a control change to occur...

My biggest problem with the class action is that unless my interpretation is wrong, Laurent Arnauts is not threatening litigation at this time. Thus, no discovery process would be conducted that migh...

I did receive an email from Laurent Arnauts. Based on the translation of the email (and it was rough) it appears that they are seeking to assemble a collective of shareholders willing to pay for thei...

The Nasdaq launch was pre-arranged as a way for White Box and High Bridge to cash out. This Fraud is so evident and was arranged years ago. Back in 2020 when the Nasdaq MDx market was trading 300% ...

BCART has literally promised to release the ABC breast cancer assay for each of the past 3 years. To do it weeks after announcing that they are discharging the existing shareholder base is criminal. ...

EuroI hope your correct. Sometimes the integrity of entire institutions are dependent on a few people that speak out against injustice and wrong doing. The entire U.S. democracy was was almost b...

BetsThanks for posting. I do not question the legality of the process. My questions go more to the point of weather company management has a fiduciary duty to shareholders. If a CEO can just c...

What is scandalous is that BCART has promised for years to release assays resulting out of this collaboration. These promises were meant to retain investors with the hope that the ecosystem&quo...

Euro, I hope your right about re-examining the fire circumstances. Although the evidence is long since gone. The 1st half 2021 Results clearly indicate that BCART was seeing the anticipated pand...

I recommend complaining about Belgian tax laws surrounding the stock exchange. They are inimitable in 99 out of 100 cases. There is a greater chance of international acclaim. Extensive warning...

Those that have read my posts over the years know that I soured on BCART the last couple years. An investor cannot keep the blinders on indefinitely. While I was an extreme bull for years, too many...

Sorry about the formatting of my post becoming contorted.The headings are:Period, Consoles sold in period, Cuml consoles sold, cartridges sold in period, yr end cartridges sold, cartridge...

The fact that BCART endured a mysterious (to my knowledge - still undetermined cause) fire at the precise moment they were showing considerable traction is probably the piece of data that most convinc...

Who will be held liable?New BCART or any reconstituted BCRT entity with Verrelst in any C suite or Board position should be banned from public markets. Unless there is a detailed discovery process,...

While the U.S. has too many frivolous lawsuits, it appears that Belgium lacks the rule of law that at least brings facts to light. Without a detailed discovery process we do not have any assurance of...

As a shareholder I accept the risk that the investment can go to zero. I sold accordingly the past two years to reduce risk and harvest losses for tax purposes. The selling was also driven by losing...

I allege that Verrest orchestrated a conspiracy against BCARTS shareholders from the moment the former management was replaced in 2018. The intent has been to wrestle control from shareholders. ...

Catch and KillI wrote about 18 months ago that I suspected that Chief Executive Officer Herman Verrelst was involved in a catch and kill or a catch and give away (to the backstop creditors) schem...

In my mind, the receipt of these payment coding designations is equally important to the FDA approval of Septicyte Rapid since it facilitates the third party payers and makes the hospitals providin...

Euro- dont get too excited about that June Tagrisso CDx announcement. As I have pointed out on this board on numerous occasions, the Idylla EGFR assay currently has little utility for Tagrisso....

The last report had the look of what we call in the US a Kitchen Sink Quarter meaning they through in all the bad news possible in order to clear the slate for the new management. With th...

GigSome of the posts are aimed in the way you suggest, but more than anything the post is meant as a shot across managements bow. It is high time to show the investor something tangible from all ...

I just think new investors need to be aware of BCARTs long history of similar big pharma announcements that never materialize in a way that aid profitability.FL...

The above quote caught my eye.The collaboration with Lilly shows the underlying potential of Idylla.JEROEN VAN DEN BOSSCHEKBC SECURITIES ANALISTI would have thought the same ab...

The BCART Share price has gone down whether I post positively, as I did thru 2021 or negatively as I have done the past couple years. I have just become very disenchanted with management. They gain ...

Im looking for a Chinese company to acquire BCART before the end of the year. Cardoza has been associated with Executive Search firm Sloan Partners who represent international Clients. BCART ha...

Okay, here is a little good news.Immunexpress Announces Adoption of SeptiCyte® RAPID by FirstHealth of the CarolinasFirstHealth is among other early adopters integrating the recently FDA cleared...

WilfroI agree that the world would be much more just if the fines were clawed back out of the then CEOs (Verrelsts) hide. It is not the case in the U.S., either. Unfortunately, I st...

Ive been doing a bit of a post mortem (yes, the BCART investment thesis pretty much dead). The following should have been indications that it was time to run.1) There were many PR announceme...

I have two divergent views on recent events at BCART.1) The recent quarter looked like a kitchen sink event. High cash burn, low console placement, low cartridge sales....etc. Perhaps they too...

BCART has placed the least number of Idylla Console units into service that I have seen for any half year period since going public. Id also be careful of the promise of numerous assay releases ...

Bonsjoer,Im not aware of the EGFR assay being submitted to FDA, yet. The AZN partnership was announced in Jan 2020, the CDx partnership was announced in June 2022 and to my knowledge, no reg...

My question is whether BCART learned any lessons that might allow faster registration approvals with the FDA. The 2 years that the MSI application was under review is nearly twice as long as a typica...

Hard to get too excited about the announcement of a new CEO. Moodys track record does not exactly appear stellar. Selling BCART at todays basement prices might enable Verrelst to claim he ...

OZBCART has burned the investment community many times on this type of front end partnership announcement. As I said once before, BCART is where partnerships go to die. The market has wised up a...

The IR Dept needs to make Slides 16, 17 and 23 more consistent, They drop Amgen on 16 and 17 but still show the partnership on #23.FL...

Now comes the interesting part. What will the insurance reimbursement costs be? Undoubtedly, the US Medicare reimbursement rate will be key. For an example here is a quick snapshot of Promega. $25...

The conference call suggests almost no interest in BCART. Worse, some of the answers to the few questions were demonstrably misleading. The answer to the FDA MSI application status suggested that t...

I think you are seeing an example of the new share issuance giving the hedge funds a chance to demonstrate the extent to which BCART is now their plaything. The company can go ahead and announce the ...

Here is one source. BCART has one of the worst charts Ive ever seen,.FL...

I always focus on Nichirei since the initial partnership PR promised a huge roll out of like 2000 Idylla consoles upon successful registration rollout throughout the Nichirei lab network. Now t...

I wouldnt get too excited until BCART can show they are executing better by scaling to reduce cash burn, introducing new assays, correcting problems with existing assays and gaining IVD usage re...